Fewer PMA Approvals In FY 1998 Anticipated By Device Center's Alpert
This article was originally published in The Gray Sheet
Executive SummaryFDA expects to approve fewer than 40 original premarket approval applications in fiscal year 1998 (ending Sept. 30), down from the prior "banner year" in which the agency okayed 48, Office of Device Evaluation Director Susan Alpert forecast at a recent Food and Drug Law Institute meeting in Washington, D.C.
You may also be interested in...
The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.
No device-related warning letters were released by the US FDA the week of 19 February.
Complex generics and value added medicines share common challenges on harmonization of regulation, lack of incentives and clarity of guidelines, heard delegates to Medicines for Europe’s Regulatory & Scientific Affairs conference.